每年專案
機構檔案
機構簡介
本科治療項目涵蓋範圍頗廣，包括肺、食道、肋膜、氣管、縱隔腔、橫膈以及胸壁疾病等，致力於先進的達文西及胸腔內視鏡微創手術之發展，秉持著以病患為中心的理念為民眾服務。目前由外科部主任禚靖教授兼任胸腔外科主任，統整及管理本科業務。全科同人致力於推廣及精進胸腔癌、含肺癌、食道癌及縱隔腔腫瘤之診治，特別著重肺癌之預防、早期診斷及治療新觀念及方式之推展；另新進資深醫師張懷陸除執行臨床及教學任務外，亦兼任本院胸腔癌團隊會議副召集人，全力協助癌症中心胸腔癌業務之發展。其間連允昌醫師自93年9月至104年4月擔任胸腔外科主任，致力於科務之推展，並於97年5月至104年4月擔任外科加護病房主任，貢獻卓著。另科內所有專任主治醫師亦肩負台北醫學大學醫學系五、六、七年級學生及PGY1之胸腔外科臨床教學訓練以及住院醫師之專科醫師訓練教學之任務；且本科自100年7月起，成為台灣胸腔及心臟外科學會所認可之胸腔外科專科訓練醫院。指紋
查看啟用 胸腔外科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
概要
-
Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma: Journal of Personalized Medicine
Huang, J-H., Chen, S-H., Liao, Y-M., Kao, Y-C., Ho, W-L., Chang, H., Tsai, M-L., Lee, H-L., Kuo, C-C., Tseng, S-H., Chang, C-Y., Hsieh, K. L., Lu, L-S., Chen, Y-J., Chiou, J-F., Hsieh, T-H., Liu, Y-R., Hsu, W., Li, W-T., Wu, Y-C., 及其他8, 2023研究成果: 其他貢獻
-
Modified En Bloc Esophagectomy for Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
Hsu, P. K., Chien, L. I., Chuang, L. C., Lee, Y. Y., Huang, C. S., Hsu, H. S., Wu, Y. C. & Hsu, W. H., 4月 2023, 於: Annals of Thoracic Surgery. 115, 4, p. 862-869 8 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Old age and EGFR mutation status in inoperable early-stage non-small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan
Wu, Y. H., Kang, Y. M., Hu, Y. W., Lan, K. L., Yen, S. H., Lai, T. Y., Lan, T. L., Chen, Y. M., Chiu, C. H., Luo, Y. H., Chao, H. S., Chiang, C. L., Shiao, T. H., Yang, C. N., Hsu, W. H., Wu, Y. C., Hsu, H. S., Hung, J. J., Huang, C. S., Hsu, P. K., 及其他1, 3月 2023, 於: Thoracic Cancer. 14, 7, p. 654-661 8 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Additional file 3: of Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuo, K. (Contributor), Huang, W. (Contributor), Bamodu, O. A. (Contributor), Lee, W. (Contributor), Wang, C. (Contributor), Hsiao, M. (Contributor), Wang, L. (Contributor) & Yeh, C. (Contributor), Unknown Publisher, 8月 9 2018
DOI: 10.6084/m9.figshare.6953543.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Histone_demethylase_JARID1B_KDM5B_promotes_aggressiveness_of_non-small_cell_lung_cancer_and_serves_as_a_good_prognostic_predictor/6953543/1
資料集: Dataset
-
Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuo, K. (Contributor), Huang, W. (Contributor), Bamodu, O. A. (Contributor), Lee, W. (Contributor), Wang, C. (Creator), Hsiao, M. (Contributor), Wang, L. (Creator) & Yeh, C. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4194263.v1, https://figshare.com/collections/Histone_demethylase_JARID1B_KDM5B_promotes_aggressiveness_of_non-small_cell_lung_cancer_and_serves_as_a_good_prognostic_predictor/4194263/1
資料集: Dataset
-
Additional file 2: of Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
Huang, W. (Contributor), Kuo, K. (Contributor), Wang, C. (Contributor), Yeh, C. (Contributor) & Wang, Y. (Contributor), Unknown Publisher, 1月 1 2019
DOI: 10.6084/m9.figshare.8057534.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Cisplatin_resistant_lung_cancer_cells_promoted_M2_polarization_of_tumor-associated_macrophages_via_the_Src_CD155_MIF_functional_pathway/8057534/1
資料集: Dataset